Halia Therapeutics Named as 2025 Top 10 Longevity Breakthrough Award Winner
October 9, 2025
Halia Therapeutics has been named one of the Top 10 Longevity Breakthrough Award Winners for 2025. This recognition reflects Halia’s mission to redefine human potential by addressing the root cause of chronic diseases: inflammation. Congratulations Halia!
Recent News
- Canyon Labs Launches Expanded Reprocessing Validation Services for Medical Devices
- Connecting with Life Sciences in Logan
- Halia Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
- Ratio Therapeutics Enters into Research Collaboration, License Agreement with RayzeBio to Advance a Novel Radiopharmaceutical Program
- Co-Diagnostics Completes New Vector Smart® Laboratory Installations Amid Rising Dengue Activity in Florida
- Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India
